Left Ventricular Functional Recovery with Percutaneous, Transvascular Direct Myocardial Delivery of Bone Marrow-Derived Cells

Percutaneous, transvascular, direct intramyocardial bone marrow cell transplantation is safe and feasible in chronically infarcted tissue. In this pilot study, cell therapy improved overall left ventricular systolic function by recruiting previously hypokinetic or akinetic myocardial tissue.